Sigrun Thorsteinsdottir
Copenhagen, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 60 publications
Clinical and Psychological Outcomes After Monoclonal Gammopathy Screening: A Population-Based Screening Study and Subsequent Randomized Trial of Follow-Up.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 14, 2026
Light Chain Monoclonal Gammopathy of Undetermined Significance: Diagnosis, Biology, and Clinical Management.
Journal: European journal of haematology
Published: May 25, 2026
Identifying High-Risk Smoldering Multiple Myeloma for Early Intervention.
Journal: JAMA oncology
Published: April 23, 2026
Redefining light-chain smoldering multiple myeloma: prevalence and progression risk.
Journal: Leukemia
Published: April 22, 2026
Detailed immunophenotypic and genetic characterization of bone marrow clonal plasma cells and B-cells in early-stage monoclonal gammopathies.
Journal: Blood cancer journal
Published: April 20, 2026
Mosaic chromosomal alterations and relation to haematological cancer in two large Danish cohorts.
Journal: British journal of haematology
Published: March 25, 2026
Prediagnostic opioid use and survival in multiple myeloma: a nationwide register-based study.
Journal: Scientific reports
Published: March 12, 2026
Revised criteria for light chain MGUS enhance diagnostic accuracy and risk stratification.
Journal: Blood cancer journal
Published: November 06, 2025
Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.
Journal: Blood cancer journal
Published: October 08, 2025
New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance.
Journal: JAMA oncology
Published: May 29, 2025
Last Updated: 09/26/2026